These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12638727)

  • 1. The pleiotropic effects of erythropoietin in the central nervous system.
    Buemi M; Cavallaro E; Floccari F; Sturiale A; Aloisi C; Trimarchi M; Corica F; Frisina N
    J Neuropathol Exp Neurol; 2003 Mar; 62(3):228-36. PubMed ID: 12638727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin (rHuEPO): more than just the correction of uremic anemia.
    Buemi M; Aloisi C; Cavallaro E; Corica F; Floccari F; Grasso G; Lasco A; Pettinato G; Ruello A; Sturiale A; Frisina N
    J Nephrol; 2002; 15(2):97-103. PubMed ID: 12018644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin and the brain: from neurodevelopment to neuroprotection.
    Buemi M; Cavallaro E; Floccari F; Sturiale A; Aloisi C; Trimarchi M; Grasso G; Corica F; Frisina N
    Clin Sci (Lond); 2002 Sep; 103(3):275-82. PubMed ID: 12193153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleiotropic functions of erythropoietin.
    Sasaki R
    Intern Med; 2003 Feb; 42(2):142-9. PubMed ID: 12636232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture.
    Nagai A; Nakagawa E; Choi HB; Hatori K; Kobayashi S; Kim SU
    J Neuropathol Exp Neurol; 2001 Apr; 60(4):386-92. PubMed ID: 11305874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain and cancer: the protective role of erythropoietin.
    Buemi M; Caccamo C; Nostro L; Cavallaro E; Floccari F; Grasso G
    Med Res Rev; 2005 Mar; 25(2):245-59. PubMed ID: 15389732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of erythropoietin receptor by nitric oxide mediates hypoxia preconditioning.
    Chen ZY; Wang L; Asavaritkrai P; Noguchi CT
    J Neurosci Res; 2010 Nov; 88(14):3180-8. PubMed ID: 20806411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin and the hypoxic brain.
    Marti HH
    J Exp Biol; 2004 Aug; 207(Pt 18):3233-42. PubMed ID: 15299044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin: multiple physiological functions and regulation of biosynthesis.
    Sasaki R; Masuda S; Nagao M
    Biosci Biotechnol Biochem; 2000 Sep; 64(9):1775-93. PubMed ID: 11055378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin biology in cancer.
    Hardee ME; Arcasoy MO; Blackwell KL; Kirkpatrick JP; Dewhirst MW
    Clin Cancer Res; 2006 Jan; 12(2):332-9. PubMed ID: 16428469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin and renoprotection.
    Bahlmann FH; Fliser D
    Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):15-20. PubMed ID: 19077684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin receptor is expressed on adult rat dopaminergic neurons and erythropoietin is neurotrophic in cultured dopaminergic neuroblasts.
    Csete M; Rodriguez L; Wilcox M; Chadalavada S
    Neurosci Lett; 2004 Apr; 359(1-2):124-6. PubMed ID: 15050726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extra-hematopoietic effects of erythropoietin.
    Cariou A; André S; Claessens YE
    Cardiovasc Hematol Disord Drug Targets; 2008 Sep; 8(3):173-8. PubMed ID: 18781929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.
    De Luisi A; Binetti L; Ria R; Ruggieri S; Berardi S; Catacchio I; Racanelli V; Pavone V; Rossini B; Vacca A; Ribatti D
    Angiogenesis; 2013 Oct; 16(4):963-73. PubMed ID: 23881169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evidence that erythropoietin protects neurons from ischemic damage.
    Sakanaka M; Wen TC; Matsuda S; Masuda S; Morishita E; Nagao M; Sasaki R
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4635-40. PubMed ID: 9539790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of erythropoietin and erythropoietin receptor in cervical cancer and relationship to survival, hypoxia, and apoptosis.
    Leo C; Horn LC; Rauscher C; Hentschel B; Liebmann A; Hildebrandt G; Höckel M
    Clin Cancer Res; 2006 Dec; 12(23):6894-900. PubMed ID: 17145806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The non-haematopoietic biological effects of erythropoietin.
    Arcasoy MO
    Br J Haematol; 2008 Apr; 141(1):14-31. PubMed ID: 18324962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma.
    Acs G; Zhang PJ; Rebbeck TR; Acs P; Verma A
    Cancer; 2002 Sep; 95(5):969-81. PubMed ID: 12209679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial and ominous aspects of the pleiotropic action of erythropoietin.
    Jelkmann W; Wagner K
    Ann Hematol; 2004 Nov; 83(11):673-86. PubMed ID: 15322761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of the erythropoietin/erythropoietin receptor system as a novel cardiovascular therapeutic target.
    Satoh K; Fukumoto Y; Nakano M; Kagaya Y; Shimokawa H
    J Cardiovasc Pharmacol; 2011 Dec; 58(6):570-4. PubMed ID: 21934628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.